Head and Neck Neoplasms

"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Descriptor ID	D006258
MeSH Number(s)	C04.588.443
Concept/Terms	Head and Neck Neoplasms Head and Neck Neoplasms Neoplasms, Head and Neck Head, Neck Neoplasms Cancer of Head and Neck Cancer of Head and Neck Head and Neck Cancer Cancer of the Head and Neck Upper Aerodigestive Tract Neoplasms Upper Aerodigestive Tract Neoplasms UADT Neoplasms Neoplasm, UADT Neoplasms, UADT UADT Neoplasm Neoplasms, Upper Aerodigestive Tract Head Neoplasms Head Neoplasms Neoplasms, Head Neck Neoplasms Neck Neoplasms Neoplasms, Neck Cancer of Head Cancer of Head Head Cancer Cancer of the Head Cancer of Neck Cancer of Neck Neck Cancer Cancer of the Neck

Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Head and Neck Neoplasms [C04.588.443]

Below are MeSH descriptors whose meaning is related to "Head and Neck Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.

Bar chart showing 555 publications over 43 distinct years, with a maximum of 35 publications in 2014

To see the data from this visualization as text, click here.

Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.

Iida M, McDaniel NK, Kostecki KL, Welke NB, Kranjac CA, Liu P, Longhurst C, Bruce JY, Hong S, Salgia R, Wheeler DL. AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer. BMC Cancer. 2022 Apr 23; 22(1):447.

View in: PubMed
Cohen EEW, Nabell L, Wong DJ, Day T, Daniels GA, Milhem M, Deva S, Jameson M, Guntinas-Lichius O, Almubarak M, Strother M, Whitman E, Chisamore M, Obiozor C, Bagulho T, Gomez-Romo J, Guiducci C, Janssen R, Gamelin E, Algazi AP. Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial. Clin Cancer Res. 2022 03 15; 28(6):1157-1166.

View in: PubMed
Taylor MH, Betts CB, Maloney L, Nadler E, Algazi A, Guarino MJ, Nemunaitis J, Jimeno A, Patel P, Munugalavadla V, Tao L, Adkins D, Goldschmidt JH, Cohen EEW, Coussens LM. Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clin Cancer Res. 2022 Mar 01; 28(5):903-914.

View in: PubMed
Bourhis J, Burtness B, Licitra LF, Nutting C, Schoenfeld JD, Omar M, Bouisset F, Nauwelaerts H, Urfer Y, Zanna C, Cohen EE. Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design. Future Oncol. 2022 May; 18(14):1669-1678.

View in: PubMed
Dolezal JM, Rosenberg AJ. Induction Chemotherapy in Low-Risk HPV+ Oropharyngeal Cancer. Curr Treat Options Oncol. 2022 Jan; 23(1):54-67.

View in: PubMed
Jeong AR, Forbes K, Orosco RK, Cohen EEW. Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report. J Otolaryngol Head Neck Surg. 2022 Feb 05; 51(1):5.

View in: PubMed
Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022 02; 126(3):361-370.

View in: PubMed
Sacco AG, Cohen EEW. Inevitable Progress-Relying on the Immune System, Not Chance. Clin Cancer Res. 2022 02 01; 28(3):435-437.

View in: PubMed
Wu J, Galvan KJ, Bogard RD, Peterson CE, Shergill A, Crowe DL. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Anticancer Res. 2021 Nov; 41(11):5393-5403.

View in: PubMed
Herzog AE, Warner KA, Zhang Z, Bellile E, Bhagat MA, Castilho RM, Wolf GT, Polverini PJ, Pearson AT, Nör JE. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells. Cell Death Dis. 2021 10 23; 12(11):988.

View in: PubMed

People

See all people

Similar Concepts

Top Journals